Incyte Announces Termination Of Phase 2 Study For Colorectal Cancer
January 27, 2016 at 21:16 PM EST
Today Incyte Corporation (INCY) decided to terminate a phase 2 study for Colorectal cancer, as an interim analysis concluded that the study didn't see enough efficacy in the combination to continue the study.
